Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

UiPath slides as ARR concerns add to broader software-sector pressure

None

UiPath (PATH) is down 4.4% today. Here is some analysis on what might have caused this price movement. ([ir.uipath.com](https://ir.uipath.com/?utm_source=openai))

Analysis: The most likely driver appears to be a negative research note that flagged possible downside risk to UiPath’s fiscal 2028 annual recurring revenue, which seems to have weighed on sentiment. The drop also came during a broader pullback in AI and software shares, so part of the move could be sector-wide de-risking rather than a new company filing or earnings update. ([gurufocus.com](https://www.gurufocus.com/news/9207944/uipath-path-shares-slip-nearly-3-amid-cleveland-research-revenue-concerns?utm_source=openai))

Details:

  • A research note circulated on November 18 highlighted concerns that UiPath’s annual recurring revenue trajectory in fiscal 2028 could face downside pressure, giving investors a fresh reason to trim positions. ([gurufocus.com](https://www.gurufocus.com/news/9207944/uipath-path-shares-slip-nearly-3-amid-cleveland-research-revenue-concerns?utm_source=openai))
  • There does not appear to be a new same-day earnings release or major corporate press release from UiPath’s investor relations site that would better explain the decline. ([ir.uipath.com](https://ir.uipath.com/?utm_source=openai))
  • Software and AI-linked stocks were broadly weak, with investors already rotating away from riskier tech names amid another volatile session for the sector. ([apnews.com](https://apnews.com/article/dad5715bc91b4aba23a567a40e22b1fc?utm_source=openai))
  • This could also be because traders remain cautious after earlier analyst skepticism around AI pricing and growth expectations, leaving PATH more vulnerable to negative incremental commentary. ([investing.com](https://www.investing.com/news/analyst-ratings/da-davidson-downgrades-uipath-stock-rating-on-ai-pricing-concerns-93CH-4919868?utm_source=openai))
  • Sources:

    GuruFocus, UiPath Investor Relations, Associated Press

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $PATH Insider Trading Activity

    PATH Insider Trades

    $PATH insiders have traded $PATH stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.

    Here’s a breakdown of recent trading of $PATH stock by insiders over the last 6 months:

    • DANIEL DINES (CEO and Chairman) has made 0 purchases and 4 sales selling 3,902,347 shares for an estimated $55,609,503.
    • RAGHAVENDRA MALPANI (CPO & CTO) has made 0 purchases and 4 sales selling 198,022 shares for an estimated $2,739,429.
    • ASHIM GUPTA (COO) has made 0 purchases and 2 sales selling 183,391 shares for an estimated $2,495,375.
    • HITESH RAMANI (Chief Accounting Officer) has made 0 purchases and 2 sales selling 50,000 shares for an estimated $831,250.
    • BRAD BRUBAKER (Chief Legal & Admin Officer) has made 0 purchases and 2 sales selling 54,808 shares for an estimated $730,549.

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    $PATH Hedge Fund Activity

    We have seen 235 institutional investors add shares of $PATH stock to their portfolio, and 375 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $PATH Analyst Ratings

    Wall Street analysts have issued reports on $PATH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

    Here are some recent analyst ratings:

    • DA Davidson issued a "Underperform" rating on 09/28/2026
    • Needham issued a "Buy" rating on 09/23/2026
    • Citigroup issued a "Buy" rating on 09/08/2026
    • B of A Securities issued a "Underperform" rating on 09/04/2026

    To track analyst ratings and price targets for $PATH, check out Quiver Quantitative's $PATH forecast page.

    $PATH Price Targets

    Multiple analysts have issued price targets for $PATH recently. We have seen 14 analysts offer price targets for $PATH in the last 6 months, with a median target of $15.0.

    Here are some recent targets:

    • Lucky Schreiner from DA Davidson set a target price of $10.0 on 09/28/2026
    • Radi Sultan from UBS set a target price of $14.0 on 09/25/2026
    • Keith Bachman from BMO Capital set a target price of $15.0 on 09/24/2026
    • Kingsley Crane from Canaccord Genuity set a target price of $14.0 on 09/24/2026
    • Bryan C. Bergin from TD Cowen set a target price of $15.0 on 09/24/2026
    • Terry Tillman from Truist Securities set a target price of $14.0 on 09/23/2026
    • Matthew Hedberg from RBC Capital set a target price of $15.0 on 09/23/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles